Defunct Company
Total Trials
8
As Lead Sponsor
5
As Collaborator
3
Total Enrollment
328
NCT00288964
Use of the Hattler Respiratory Assist Catheter in Severe Respiratory Failure
Phase: Phase 3
Role: Lead Sponsor
Start: Nov 30, 2005
Completion: Not specified
NCT00987740
Feasibility Study of the Hemolung Respiratory Assist System
Phase: N/A
Start: Oct 31, 2009
Completion: Aug 31, 2010
NCT01021605
Feasibility Study of the Hemolung Respiratory Assist System (Germany)
Start: Dec 31, 2009
Completion: May 31, 2012
NCT01855815
Hemolung RAS Registry Program
Start: Apr 30, 2013
Completion: Dec 31, 2019
NCT02086084
ECCO2R as an Adjunct to NIV in AECOPD
Role: Collaborator
Start: Dec 1, 2015
Completion: Dec 31, 2020
NCT02586948
Physiological Study of Minimally Invasive ECCO2R in Exacerbations of COPD Requiring Invasive Mechanical Ventilation
Start: Jul 31, 2016
Completion: Feb 12, 2018
NCT03255057
Extracorporeal CO2 Removal With the Hemolung RAS for Mechanical Ventilation Avoidance During Acute Exacerbation of COPD
Start: Feb 18, 2018
Completion: Aug 17, 2022
NCT07197671
Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer
Phase: Phase 1
Start: Nov 30, 2025
Completion: Jul 31, 2028